— Know what they know.
Not Investment Advice

STOK

Stoke Therapeutics, Inc.
1W: +1.0% 1M: -2.5% 3M: +2.0% YTD: +8.4% 1Y: +305.7% 3Y: +266.2% 5Y: -35.6%
$33.51
+0.32 (+0.96%)
After Hours: $35.94 (+2.43, +7.25%)
NASDAQ · Healthcare · Biotechnology · $2.0B · Alpha Radar Neutral · Power 58
Last Earnings 2026-03-17
EPS
$-0.99
▼ Miss -8.1%
Revenue
$1M
▼ Miss -77.5%
Next Earnings 2026-03-30
EPS Estimate
$-0.76
Range: $-0.80 - $-0.72
Revenue Estimate
$7M
5 analysts

Estimate vs Actual

Earnings Surprise History

12/20
EPS Beats
12/20
Revenue Beats
60%
EPS Beat Rate
60%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-03-20 quarter 2025-12-31 $-0.90 $-0.92 ▼ 0.02 $1,817,167 $1,658,833
2026-03-20 quarter 2026-12-31 $-0.89 $-0.90 ▼ 0.01 $8,181,818 $8,236,364
2026-03-20 annual 2028-12-31 $-2.06 $-2.15 ▼ 0.09 $119,403,111 $124,147,556
2026-03-20 quarter 2026-09-30 $-0.84 $-0.86 ▼ 0.02 $7,163,636 $7,218,182
2026-03-20 annual 2025-12-31 $-0.06 $-0.07 ▼ 0.02 $184,630,000 $184,471,667
2026-03-20 annual 2027-12-31 $-3.12 $-3.16 ▼ 0.04 $48,699,800 $49,249,800
2026-03-20 quarter 2026-06-30 $-0.80 $-0.82 ▼ 0.02 $7,054,545 $7,109,091
2026-03-20 annual 2026-12-31 $-3.34 $-3.38 ▼ 0.04 $26,958,333 $27,158,333
2026-03-20 annual 2029-12-31 $0.17 $0.09 ▼ 0.09 $320,171,222 $335,193,444
2026-03-20 quarter 2026-03-31 $-0.80 $-0.81 ▼ 0.01 $7,018,182 $7,072,727
2026-03-19 annual 2025-12-31 $0.09 $-0.06 ▼ 0.15 $188,569,667 $184,630,000
2026-03-19 quarter 2024-03-31 $— $-0.61 ▼ 0.61 $3,260,250
2026-03-19 quarter 2026-06-30 $-0.77 $-0.80 ▼ 0.04 $7,450,000 $7,054,545
2026-03-19 quarter 2027-06-30 $-0.90 $-0.92 ▼ 0.02 $5,750,000 $5,500,000
2026-03-19 quarter 2026-12-31 $— $-0.89 ▼ 0.89 $8,181,818
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms